These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
304 related articles for article (PubMed ID: 30700476)
1. Meta-analysis of the diagnostic value of Wisteria floribunda agglutinin-sialylated mucin1 and the prognostic role of mucin1 in human cholangiocarcinoma. Tang Z; Yang Y; Wang X; Meng W; Li X BMJ Open; 2019 Jan; 9(1):e021693. PubMed ID: 30700476 [TBL] [Abstract][Full Text] [Related]
2. Wisteria floribunda agglutinin-sialylated mucin core polypeptide 1 is a sensitive biomarker for biliary tract carcinoma and intrahepatic cholangiocarcinoma: a multicenter study. Shoda J; Matsuda A; Shida T; Yamamoto M; Nagino M; Tsuyuguchi T; Yasaka T; Tazuma S; Uchiyama K; Unno M; Ohkohchi N; Nakanuma Y; Kuno A; Narimatsu H J Gastroenterol; 2017 Feb; 52(2):218-228. PubMed ID: 27358229 [TBL] [Abstract][Full Text] [Related]
3. Verification of WFA-Sialylated MUC1 as a Sensitive Biliary Biomarker for Human Biliary Tract Cancer. Yamaguchi T; Yokoyama Y; Ebata T; Matsuda A; Kuno A; Ikehara Y; Shoda J; Narimatsu H; Nagino M Ann Surg Oncol; 2016 Feb; 23(2):671-7. PubMed ID: 26416714 [TBL] [Abstract][Full Text] [Related]
4. Glycoproteomics-based cancer marker discovery adopting dual enrichment with Wisteria floribunda agglutinin for high specific glyco-diagnosis of cholangiocarcinoma. Matsuda A; Kuno A; Matsuzaki H; Kawamoto T; Shikanai T; Nakanuma Y; Yamamoto M; Ohkohchi N; Ikehara Y; Shoda J; Hirabayashi J; Narimatsu H J Proteomics; 2013 Jun; 85():1-11. PubMed ID: 23612463 [TBL] [Abstract][Full Text] [Related]
5. Wisteria floribunda agglutinin-positive mucin 1 is a sensitive biliary marker for human cholangiocarcinoma. Matsuda A; Kuno A; Kawamoto T; Matsuzaki H; Irimura T; Ikehara Y; Zen Y; Nakanuma Y; Yamamoto M; Ohkohchi N; Shoda J; Hirabayashi J; Narimatsu H Hepatology; 2010 Jul; 52(1):174-82. PubMed ID: 20578261 [TBL] [Abstract][Full Text] [Related]
6. Diagnostic Accuracy of Serum CA19-9 in Patients with Cholangiocarcinoma: A Systematic Review and Meta-Analysis. Liang B; Zhong L; He Q; Wang S; Pan Z; Wang T; Zhao Y Med Sci Monit; 2015 Nov; 21():3555-63. PubMed ID: 26576628 [TBL] [Abstract][Full Text] [Related]
8. Serum Wisteria Floribunda Agglutinin-Positive Sialylated Mucin 1 as a Marker of Progenitor/Biliary Features in Hepatocellular Carcinoma. Tamaki N; Kuno A; Matsuda A; Tsujikawa H; Yamazaki K; Yasui Y; Tsuchiya K; Nakanishi H; Itakura J; Korenaga M; Mizokami M; Kurosaki M; Sakamoto M; Narimatsu H; Izumi N Sci Rep; 2017 Mar; 7(1):244. PubMed ID: 28325920 [TBL] [Abstract][Full Text] [Related]
9. Peptidase inhibitor 15 as a novel blood diagnostic marker for cholangiocarcinoma. Jiang Y; Zheng X; Jiao D; Chen P; Xu Y; Wei H; Qian Y EBioMedicine; 2019 Feb; 40():422-431. PubMed ID: 30638862 [TBL] [Abstract][Full Text] [Related]
10. Application of Joint Detection of AFP, CA19-9, CA125 and CEA in Identification and Diagnosis of Cholangiocarcinoma. Li Y; Li DJ; Chen J; Liu W; Li JW; Jiang P; Zhao X; Guo F; Li XW; Wang SG Asian Pac J Cancer Prev; 2015; 16(8):3451-5. PubMed ID: 25921161 [TBL] [Abstract][Full Text] [Related]
11. High Bile Titer and High Bile to Serum Ratio of CYFRA 21 - 1 Reliably Discriminate Malignant Biliary Obstruction Caused by Cholangiocarcinoma. Chen J; Liang J; Xu B; Liang J; Ma M; Wang Z; Zeng G; Xu Q; Liang L; Lai J; Huang L J Gastrointest Cancer; 2024 Jun; 55(2):800-808. PubMed ID: 38280173 [TBL] [Abstract][Full Text] [Related]
12. Diagnostic value of microRNAs as biomarkers for cholangiocarcinoma. Liang Z; Liu X; Zhang Q; Wang C; Zhao Y Dig Liver Dis; 2016 Oct; 48(10):1227-32. PubMed ID: 27476468 [TBL] [Abstract][Full Text] [Related]
13. Detection of serum MMP-7 and MMP-9 in cholangiocarcinoma patients: evaluation of diagnostic accuracy. Leelawat K; Sakchinabut S; Narong S; Wannaprasert J BMC Gastroenterol; 2009 Apr; 9():30. PubMed ID: 19405942 [TBL] [Abstract][Full Text] [Related]
14. Wisteria floribunda Agglutinin and Its Reactive-Glycan-Carrying Prostate-Specific Antigen as a Novel Diagnostic and Prognostic Marker of Prostate Cancer. Hagiwara K; Tobisawa Y; Kaya T; Kaneko T; Hatakeyama S; Mori K; Hashimoto Y; Koie T; Suda Y; Ohyama C; Yoneyama T Int J Mol Sci; 2017 Jan; 18(2):. PubMed ID: 28134773 [No Abstract] [Full Text] [Related]
15. The diagnostic efficacy of CYFRA21-1 on intrahepatic cholangiocarcinoma: A meta-analysis. Guowei H; Yuan L; Ma L; Zhongyang L; Zhixing S; Lin L; Minqi L Clin Res Hepatol Gastroenterol; 2019 Jun; 43(3):266-272. PubMed ID: 30503663 [TBL] [Abstract][Full Text] [Related]
16. A Novel Serum Glycobiomarker for Diagnosis and Prognosis of Cholangiocarcinoma Detected by Teeravirote K; Luang S; Waraasawapati S; Boonsiri P; Wongkham C; Wongkham S; Silsirivanit A Molecules; 2021 May; 26(9):. PubMed ID: 34066878 [TBL] [Abstract][Full Text] [Related]
17. The clinical utility and limitations of serum carbohydrate antigen (CA19-9) as a diagnostic tool for pancreatic cancer and cholangiocarcinoma. Singh S; Tang SJ; Sreenarasimhaiah J; Lara LF; Siddiqui A Dig Dis Sci; 2011 Aug; 56(8):2491-6. PubMed ID: 21516323 [TBL] [Abstract][Full Text] [Related]
18. [The value of CA19-9 and CEA in predicting resectability of hilar cholangiocarcinoma]. Zong D; Zeng Y Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 Sep; 45(5):819-22. PubMed ID: 25341348 [TBL] [Abstract][Full Text] [Related]
19. The diagnostic performance of serum MUC5AC for cholangiocarcinoma: A systematic review and meta-analysis. Xuan J; Li J; Zhou Z; Zhou R; Xu H; Wen W Medicine (Baltimore); 2016 Jun; 95(24):e3513. PubMed ID: 27310944 [TBL] [Abstract][Full Text] [Related]
20. Proteomics analysis and evaluation of biomarkers for detection of cholangiocarcinoma. Sriwanitchrak P; Viyanant V; Chaijaroenkul W; Srivatanakul P; Gram HR; Eursiddhichai V; Na-Bangchang K Asian Pac J Cancer Prev; 2011; 12(6):1503-10. PubMed ID: 22126489 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]